Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека АбfiledCriticalАстразенека Аб
Priority claimed from PCT/SE2008/050950external-prioritypatent/WO2009025618A1/en
Publication of UA102523C2publicationCriticalpatent/UA102523C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
The present invention relates to the use of 2-thioxo-l, 2,3,5-tetrahydro-pyrrolo[3,2-d]pyrimidine-4-one, thioxan-thine and 2-thioxo-],2,3,7-tetrahydro-6H-purin-6-one derivatives as MPO inhibitors for the treatment of multiple system atrophy (MSA), Huntington' s disease (HD).
UAA201000936A2007-08-232008-08-22Use of myeloperoxidase inhibitors for the treatment of multiple system atrophy
UA102523C2
(en)
Novel benzothiazole and benzoxazole linked pyrrolo (2,1-C) (1,4) benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof